 |
|
|
|
|
|
| |
2009
-
20Oct
Tuesday, October 20, 2009 ¬
17:40:20
NexMed Confirms NASDAQ Hearing Date
-
14Oct
Wednesday, October 14, 2009 ¬
17:40:20
NexMed Provides Update on Anti-Fungal Product
-
27Aug
Thursday, August 27, 2009¬
17:40:20
NexMed Submits Compliance Plan to NASDAQ
-
14Aug
Friday, August 14, 2009¬
17:40:20
NexMed Receives NASDAQ Delisting Warning Letter
-
07Aug
Friday, August 07, 2009¬
17:40:20
NexMed Announces Second Quarter 2009 Financial Results Conference Call
-
07Jul
Tuesday, July 07, 2009¬
17:40:20
NexMed Announces Decision for Anti-Fungal Product
-
11May
Monday, May 11, 2009¬
17:40:20
NexMed Reports First Quarter 2009 Financial and Operational Results
-
14Apr
Tuesday, April 14, 2009¬
17:40:20
NexMed Engages FTN Equity Capital Markets Corp.
-
24Mar
Tuesday, March 24, 2009¬
17:40:20
NexMed Receives NASDAQ Delisting Warning Letter
-
16Mar
Monday, March 16, 2009¬
17:40:20
NexMed Reports 2008 Year End Financial and Operational Results
-
06Mar
Friday, March 6, 2009¬
17:40:20
NexMed Announces Presentation of Data at the 67th Annual Meeting of the American Academy of Dermatology
-
03Feb
Tuesday, February 03, 2009¬
17:40:20
NexMed to Present at the 11th Annual BIO CEO & Investor Conference
-
03Feb
Tuesday, February 03, 2009¬
17:40:20
NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment
-
22Jan
Thursday, January 22, 2009¬
17:40:20
PII and NexMed Enter Into Strategic Collaboration Agreement for NexMed's NexACT® drug delivery Platform
|
|
 |